Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Replimune Group Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). The...
-
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Planet Fitness, Inc. (“Planet Fitness” or the “Company”) (NYSE: PLNT) securities to contact Lauren...
-
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Pathward Financial, Inc. (“Pathward” or the “Company”) (NASDAQ: CASH). The...
-
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR)....
-
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased GPGI, Inc. (“GPGI” or the “Company”) (NYSE: GPGI) securities to contact Lauren Molinaro of Kirby...
-
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ: ADTN). The...
-
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) securities to contact Lauren Molinaro...
-
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA). The...
-
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Celcuity Inc. (“Celcuity” or the “Company”) (Nasdaq: CELC). The...
-
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Pentair plc (“Pentair” or the “Company”) (NYSE: PNR). The investigation...